These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25209563)

  • 1. Do normal Egyptians possess anti-desmoglein 3 antibodies?
    Saleh MA; El-Bahy MM
    Int J Dermatol; 2015 Oct; 54(10):1145-9. PubMed ID: 25209563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
    Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
    J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
    Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
    Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
    Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
    Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
    Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
    J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidesmoglein 1 and 3 antibodies in healthy subjects of a population in the Peruvian high amazon.
    Ramos W; Díaz J; Gutierrez EL; Lazarte JS; Bohnett MC; Ronceros G; Ortega-Loayza AG
    Int J Dermatol; 2018 Mar; 57(3):344-348. PubMed ID: 29130480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of total serum IgG4 in patients with pemphigus.
    Funakoshi T; Lunardon L; Ellebrecht CT; Nagler AR; O'Leary CE; Payne AS
    Br J Dermatol; 2012 Dec; 167(6):1245-53. PubMed ID: 22803659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil.
    Hilario-Vargas J; Dasher DA; Li N; Aoki V; Hans-Filho G; dos Santos V; Qaqish BF; Rivitti EA; Diaz LA;
    J Invest Dermatol; 2006 Sep; 126(9):2044-8. PubMed ID: 16763546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lateral flow immunoassay for the rapid detection of anti-Dsg3 IgG serum autoantibodies in pemphigus vulgaris.
    Schmidt T; Mauracher S; Bender L; Greene B; Kurzhals J; Eming R; Dostatni R; Hertl M
    Exp Dermatol; 2018 Mar; 27(3):233-237. PubMed ID: 29278440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential.
    Ketabi Y; Nasiri S; Kheirodin M; Tavakolpour S; Mozafari N
    Dermatol Ther; 2019 Jul; 32(4):e12973. PubMed ID: 31136685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.
    Bhol K; Natarajan K; Nagarwalla N; Mohimen A; Aoki V; Ahmed AR
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5239-43. PubMed ID: 7761479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris.
    Bhol K; Mohimen A; Ahmed AR
    Dermatology; 1994; 189 Suppl 1():85-9. PubMed ID: 8049571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab.
    Golinski ML; Lemieux A; Maho-Vaillant M; Barray M; Drouot L; Schapman D; Petit M; Hertl M; Boyer O; Calbo S; Joly P; Hébert V
    Front Immunol; 2022; 13():849790. PubMed ID: 35371083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris.
    Sinistro A; Calabresi V; Lupi F; Sera F; Frezzolini A; Ruffelli M; De Pità O; Camaioni D; Cianchini G; Di Zenzo G
    Eur J Dermatol; 2015; 25(6):578-85. PubMed ID: 26552329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary desmoglein enzyme-linked immunosorbent assay for diagnosis of pemphigus vulgaris: a noninvasive alternative test to serum assessment.
    Mortazavi H; Khatami A; Seyedin Z; Vasheghani Farahani I; Daneshpazhooh M
    Biomed Res Int; 2015; 2015():698310. PubMed ID: 25688364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a "hit-and-run" mechanism.
    Lin L; Moran TP; Peng B; Yang J; Culton DA; Che H; Jiang S; Liu Z; Geng S; Zhang Y; Diaz LA; Qian Y
    J Allergy Clin Immunol; 2019 Sep; 144(3):720-728.e4. PubMed ID: 31071340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.